(Q54033324)

English

Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.

scientific article published in October 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Uzun O

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

Arikan S

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

Kocagöz S

3

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

Sancak B

4

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

Unal S

5

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

publication date

1 October 2000

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

38

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

101-107

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Azole Antifungal Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluconazole-resistant Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amphotericin B resistance testing of Candida spp.: a comparison of methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro evaluation of voriconazole against some clinically important fungi

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fungal infections in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of amphotericin B-resistant Candida isolates in a broth-based system

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Problems and controversies in the management of hematogenous candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900177-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(00)00177-2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11035241

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54033324&oldid=1565999508"